For years, prostate cancer screening procedures have often been confusing for men. The primary screening tool used was a blood test to measure PSA ( Prostate-Specific Antigen ) , a chemical naturally produced by the prostate gland.
The good news is that medicine has made rapid progress. The diagnostic process no longer relies solely on a single PSA blood test, but has shifted to a multistep approach that is far more accurate, safer, and minimizes unnecessary medical interventions.
Understanding the Role and Limitations of the PSA Test
PSA levels in the blood are used as an early indicator of prostate health, with general guidelines as follows:
- Below 4 ng/mL: The risk of developing cancer is low.
- Between 4 and 9.9 ng/mL (Intermediate Levels): An increase in this level does not necessarily indicate cancer. It is often caused by common, harmless conditions, such as benign prostatic hyperplasia (BPH) or prostate inflammation (prostatitis). If cancer is caused, it is usually a low-grade, slow-growing cancer.
- 10 ng/mL or Higher: The risk of prostate cancer is higher and requires in-depth examination.
What medical teams are most concerned about isn't just a slight increase, but rather the rapidity of the PSA spike in a short period of time (for example, jumping from 3 ng/mL to 3.8 ng/mL or more in a few months). This rapid increase indicates a more aggressive type of cancer that requires immediate treatment.
Changing Medical Standards: Abandoning Hasty Biopsy
In the past, men with high or rapidly rising PSA levels were usually immediately faced with a difficult binary choice: undergo a biopsy (an invasive procedure involving the removal of prostate tissue that carries the risk of pain, bleeding, or infection) or simply have repeated blood tests and a digital rectal exam.
In the past, doctors also used two modified PSA methods to help make decisions:
- Free PSA : Measures the level of PSA that is not bound to protein. If the percentage is very low (below 10%), the risk of aggressive cancer is higher.
- PSA Density : The total PSA level divided by the prostate volume. A value of 0.15 ng/mL or higher indicates a risk of cancer.
Today, thanks to modern healthcare standards that prioritize patient comfort and safety, a man with an above-normal PSA result will not be taken straight to the biopsy room.
Three Recent Advances in Prostate Cancer Screening
Today's diagnostic process is much more measurable through a multidimensional approach that combines imaging technology and molecular biology examinations:
1. Use of Prostate MRI (Greatest Advancement)
Currently, if your PSA test results are abnormal, your doctor will recommend an MRI ( Magnetic Resonance Imaging ) scan first before deciding on any other course of action.
- If the MRI results are negative (do not detect any suspicious areas), the patient can avoid the biopsy procedure and simply be monitored periodically with blood tests.
- If the MRI results are positive , a new biopsy will be performed. The advantage of an MRI is that it acts as a road map, allowing the doctor to perform a targeted biopsy precisely at the suspected cancer site without damaging surrounding healthy tissue.
2. Biomarker Examination Through Special Urine Tests
To complement MRI results, doctors can now use patient urine samples to look for cancer biomarkers :
- PCA3 test: Measures a specific protein whose production spikes when prostate cells become cancerous.
- HOXC6 and DLX1 tests: Identifies genetic material (mRNA) to predict whether the cancer has the potential to spread widely or is considered non-aggressive.
3. Transition to Active Surveillance Methods
Many senior doctors who were once reluctant to recommend PSA testing are now backing regular screening thanks to the advent of active surveillance . This method allows men diagnosed with low-grade cancer to avoid immediate surgery or radiation. Patients can simply be closely and safely monitored over time, maintaining their quality of life without the side effects of aggressive treatment.
When Should You Consult a Doctor at EMC Hospital Tangerang?
For men over 50 (or over 45 if they have a family history of prostate cancer), it's recommended to discuss scheduling regular prostate screening with a urologist . Modern screening methods are designed to provide a precise, targeted diagnosis tailored to your individual needs.
EMC Tangerang Hospital offers superior services for men's health, specifically urology care. Our urologists and general surgeons are ready to assist with the latest medical technology and safe, minimally invasive procedures. We are here not only as a medical team but also as a companion on your journey of recovery, from initial examination to full recovery.
This article was written by Dr. Mochamad Sri Herlambang, Sp.U. FICS (Urology Surgeon Specialist at EMC Tangerang Hospital).